Form 8-K - Current report:
SEC Accession No. 0001437749-24-036376
Filing Date
2024-11-29
Accepted
2024-11-29 16:30:26
Documents
14
Period of Report
2024-11-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20241129_8k.htm   iXBRL 8-K 26584
  Complete submission text file 0001437749-24-036376.txt   159005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlph-20241127.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20241127_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20241127_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20241127_pre.xml EX-101.PRE 11585
16 EXTRACTED XBRL INSTANCE DOCUMENT acrx20241129_8k_htm.xml XML 2834
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 241516633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)